1. Home
  2. TAP vs QGEN Comparison

TAP vs QGEN Comparison

Compare TAP & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Molson Coors Beverage Company Class B

TAP

Molson Coors Beverage Company Class B

HOLD

Current Price

$43.25

Market Cap

10.1B

ML Signal

HOLD

Logo Qiagen N.V.

QGEN

Qiagen N.V.

HOLD

Current Price

$39.17

Market Cap

10.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TAP
QGEN
Founded
1873
1986
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Beverages (Production/Distribution)
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Staples
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.1B
10.2B
IPO Year
N/A
1998

Fundamental Metrics

Financial Performance
Metric
TAP
QGEN
Price
$43.25
$39.17
Analyst Decision
Hold
Buy
Analyst Count
16
9
Target Price
$50.00
$51.30
AVG Volume (30 Days)
2.5M
1.9M
Earning Date
05-07-2026
05-06-2026
Dividend Yield
4.58%
6.07%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$0.83
$8.18
Revenue Next Year
$0.16
$5.66
P/E Ratio
N/A
$24.01
Revenue Growth
N/A
N/A
52 Week Low
$41.04
$38.13
52 Week High
$63.40
$57.82

Technical Indicators

Market Signals
Indicator
TAP
QGEN
Relative Strength Index (RSI) 41.98 27.02
Support Level N/A N/A
Resistance Level $47.36 $49.11
Average True Range (ATR) 1.02 0.96
MACD 0.02 -0.02
Stochastic Oscillator 42.63 5.91

Price Performance

Historical Comparison
TAP
QGEN

About TAP Molson Coors Beverage Company Class B

Molson Coors owns well-known beer brands including Miller, Coors, Blue Moon, and Carling and ranks as the second-largest beer maker in both value and volume terms in the US, Canada, and the United Kingdom. Through licensing agreements, the firm also brews and distributes beer and hard seltzer under partner brands from Heineken, Anheuser-Busch InBev, Asahi, and Coca-Cola. The brewer uses independent distributors in the US, given the three-tier distribution requirements, while using a combination of distributors and an in-house sales team in Canada and Europe. North America remains its largest market, contributing over 80% of total revenue.

About QGEN Qiagen N.V.

Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).

Share on Social Networks: